Private Capital Advisors, Inc. Abb Vie Inc. Transaction History

Private Capital Advisors, Inc.

$803 Million
Q1 2024

A detailed history of Private Capital Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Private Capital Advisors, Inc. holds 59,585 shares of ABBV stock, worth $10.2 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

59,585

Previous 59,835 0.42%

Holding current value

$10.2 Million

Previous $9.27 Million 17.01%

% of portfolio

1.35%

Previous 1.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 0.42%	59,585 $10.9 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $1.3 Million - $1.46 Million	-9,448 Reduced 13.64%	59,835 $9.27 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $9,752 - $11,289	-73 Reduced 0.11%	69,283 $9.78 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $484,324 - $602,709	-3,655 Reduced 5.01%	69,356 $9.34 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $2.95 Million - $3.4 Million	-20,433 Reduced 21.87%	73,011 $11.6 Million

Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $10,065 - $11,544	-75 Reduced 0.08%	93,444 $12.5 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $3,440 - $4,374	25 Added 0.03%	93,519 $14.3 Million
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $164,975 - $204,687	-1,250 Reduced 1.32%	93,494 $15.2 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $125,370 - $158,630	-1,167 Reduced 1.22%	94,744 $12.8 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $133,000 - $150,975	1,250 Added 1.32%	95,911 $10.3 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $55,340 - $61,652	-526 Reduced 0.55%	94,661 $10.7 Million
Q1 2021 May 03, 2021	SELL	$102.3 - $112.62 $3.24 Million - $3.57 Million	-31,695 Reduced 24.98%	95,187 $10.3 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $31,013 - $36,399	361 Added 0.29%	126,882 $11.1 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $73,370 - $98,180	-1,000 Reduced 0.78%	126,521 $12.4 Million
Q1 2020 Apr 15, 2020	BUY	$64.5 - $97.79 $365,650 - $554,371	5,669 Added 4.65%	127,521 $9.72 Million
Q4 2019 Jan 09, 2020	BUY	$72.13 - $90.25 $68,523 - $85,737	950 Added 0.79%	121,852 $10.8 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $506,989 - $609,546	8,050 Added 7.13%	120,902 $9.16 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $5.05 Million - $6.46 Million	76,892 Added 213.83%	112,852 $8.21 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $19,285 - $22,697	-250 Reduced 0.69%	35,960 $2.9 Million
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $463,221 - $514,956	-5,210 Reduced 12.58%	36,210 $3.43 Million
Q3 2018 Oct 12, 2018	BUY	$88.91 - $98.84 $463,221 - $514,956	5,210 Added 14.39%	41,420 $3.68 Million
Q2 2018 Jul 10, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 0.28%	36,210 $3.36 Million
Q4 2017 Jan 12, 2018	SELL	$89.56 - $98.21 $457,651 - $501,853	-5,110 Reduced 12.34%	36,310 $3.51 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $2.89 Million - $3.7 Million	41,420	41,420 $3.68 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.

Account

Private Capital Advisors, Inc. Abb Vie Inc. Transaction History